Estrogens are the best-studied class of drugs for potential use in the prevention of Alzheimer's disease (AD). These steroids have been shown to be potent neuroprotectants both in vitro and in vivo, and to exert effects that are consistent with their potential use in prevention of AD. These include the prevention of the processing of amyloid precursor protein (APP) into beta-amyloid (Aβ), the reduction in tau hyperphosphorylation, and the elimination of catastrophic attempts at neuronal mitosis. Further, epidemiological data support the efficacy of early postmenopausal use of estrogens for the delay or prevention of AD. Collectively, this evidence supports the further development of estrogen-like compounds for prevention of AD. Several approaches to enhance brain specificity of estrogen action are now underway in an attempt to reduce the side effects of chronic estrogen therapy in AD.
Aisen, P., Albert, M., Breitner, J.C.S., Buckholtz, N., Corey-Bloom, J.P., Cummings, J.L. et al. (2008) Preventing dementia: following in Leon Thal's footsteps, Alzheimer's Dementia4: 156-163.
2.
Alkayed, N.J., Harukuni, I., Kimes, A.S., London, E.D., Traystman, R.J. and Hurn, P.D. (1998) Gender-linked brain injury in experimental stroke , Stroke29: 159-165.
3.
Altieri, M., Di Piero, V., Pasquini, M., Gasparini, M., Vanacore, N., Vicenzini, E. et al. (2004) Delayed poststroke dementia: a 4-year follow-up study, Neurology62: 2193-2197.
4.
Anderson, G.L., Limacher, M., Assaf, A.R., Bassford, T., Beresford, S.A., Black, H. et al. (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA291: 1701-1712.
5.
Ayres, S., Tang, M. and Subbiah, M.T. (1996) Estradiol-17beta as an antioxidant: some distinct features when compared with common fat-soluble antioxidants, J Lab Clin Med128: 367-375.
6.
Ba, F., Pang, P.K. and Benishin, C.G. (2004) The role of Ca2+ channel modulation in the neuroprotective actions of estrogen in beta-amyloid protein and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) cytotoxic models, Neurochem Int45: 31-38.
7.
Bae, Y.H., Hwang, J.Y., Kim, Y.H. and Koh, J.Y. (2000) Anti-oxidative neuroprotection by estrogens in mouse cortical cultures, J Korean Med Sci15: 327- 336.
8.
Bagetta, G., Chiappetta, O., Amantea, D., Iannone, M., Rotiroti, D., Costa, A. et al. (2004) Estradiol reduces cytochrome c translocation and minimizes hippocampal damage caused by transient global ischemia in rat , Neurosci Lett368: 87-91.
9.
Bayir, H., Marion, D.W., Puccio, A.M., Wisniewski, S.R., Janesko, K.L., Clark, R.S. and Kochanek, P.M. (2004) Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients, J Neurotrauma21: 1-8.
10.
Bederson, J.B., Pitts, L.H., Tsuji, M., Nishimura, M.C., Davis, R.L. and Bartkowski, H. (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination, Stroke17: 472-476.
11.
Behl, C., Widmann, M., Trapp, T. and Holsboer, F. (1995) 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro, Biochem Biophys Res Commun216: 473-482.
12.
Behl, C., Skutella, T., Lezoualc'h, F., Post, A., Widmann, M., Newton, C.J. et al. (1997) Neuroprotection against oxidative stress by estrogens: structure-activity relationship, Mol Pharmacol51: 535-541.
13.
Berco, M. and Bhavnani, B.R. (2001) Differential neuroprotective effects of equine estrogens against oxidized low density lipoprotein-induced neuronal cell death , J Soc Gynecol Investig8: 245-254.
14.
Bettini, E. and Maggi, A. (1992) Estrogen induction of cytochrome c oxidase subunit III in rat hippocampus, J Neurochem58: 1923-1929.
15.
Bhavnani, B.R., Cecutti, A., Gerulath, A., Woolever, A.C. and Berco, M. (2001) Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women, Menopause8: 408-419.
16.
Biewenga, E., Cabell, L. and Audesirk, T. (2005) Estradiol and raloxifene protect cultured SN4741 neurons against oxidative stress, Neurosci Lett373: 179-183.
17.
Bishop, J. and Simpkins, J.W. (1994) Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro, Mol Cell Neurosci5: 303-308.
18.
Blum-Degen, D., Haas, M., Pohli, S., Harth, R., Roömer, W., Oettel, M. et al. (1998) Scavestrogens protect IMR 32 cells from oxidative stress-induced cell death, Toxicol Appl Pharmacol152: 49-55.
19.
Bonnefont, A.B., Munoz, F.J. and Inestrosa, N.C. (1998) Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes, FEBS Lett441: 220-224.
20.
Bornstein, N.M., Gur, A.Y., Treves, T.A., Reider-Groswasser, I., Aronovich, B.D., Klimovitzky, S.S. et al. (1996) Do silent brain infarctions predict the development of dementia after first ischemic stroke? Stroke27: 904-905.
21.
Brinton, R.D., Chen, S., Montoya, M., Hsieh, D. and Minaya, J. (2000) The estrogen replacement therapy of theWomen's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease, Maturitas34(Suppl. 2): S35-S52.
22.
Brinton, R.D. (2004) Requirements of a brain selective estrogen: advances and remaining challenges for developing a NeuroSERM, J Alzheimers Dis6(Suppl. 6): S27-35.
23.
Brooke, S.M. and Sapolsky, R.M. (2000) The effects of steroid hormones in HIV-related neurotoxicity: a mini review, Biol Psychiatry48: 881-893.
24.
Bruce-Keller, A.J., Barger, S.W., Moss, N., Pham, J.T., Keller, J.N. and Nath, A. (2001) Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17 beta-estradiol , J Neurochem78: 1315-1324.
25.
Bruce-Keller, A.J., Keeling, J.L., Keller, J.N., Huang, F.F., Camondola, S. and Mattson, M.P. (2000) Antiinflammatory effects of estrogen on microglial activation, Endocrinology141: 3646-3656.
26.
Carlson, L.E. and Sherwin, B.B. (1998) Steroid hormones, memory and mood in a healthy elderly population [In Process Citation], Psychoneuroendocrinology23: 583-603.
27.
Carroll, J.C., Rosario, E.R., Chang, L., Stanczyk, F.Z., Oddo, S., LaFerla, F.M. and Pike, C.J. (2007) Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice, J Neurosci27: 13357-65.
28.
Carswell, H.V., Dominiczak, A.F. and Macrae, I.M. (2000) Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats, Am J Physiol Heart Circ Physiol278: H290-H294.
29.
Chae, H.S., Bach, J.H., Lee, M.W., Kim, H.S., Kim, Y.S., Kim, K.Y. et al. (2001) Estrogen attenuates cell death induced by carboxy-terminal fragment of amyloid precursorprotein in PC12 through a receptor-dependent pathway, J Neurosci Res65: 403-407.
30.
Chang, D., Kwan, J. and Timiras, P.S. (1997) Estrogens influence growth, maturation, and amyloid beta-peptide production in neuroblastoma cells and in a beta-APP transfected kidney 293 cell line, Adv Exp Med Biol429: 261-271.
31.
Chen, J., Delannoy, M., Odwin, S., He, P., Trush, M.A. and Yager, J.D. (2003) Enhanced mitochondrial gene transcript, ATP, bcl-2 protein levels, and altered glutathione distribution in ethinyl estradiol-treated cultured female rat hepatocytes, Toxicol Sci75: 271-278.
32.
Chen, J.Q., Eshete, M., Alworth, W.L. and Yager, J.D. (2004a) Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements, J Cell Biochem93: 358-373.
33.
Chen, J.Q., Delannoy, M., Cooke, C. and Yager, J.D. (2004b) Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells, Am J Physiol Endocrinol Metab286: E1011-E1022.
34.
Chen, J.Q. and Yager, J.D. (2004) Estrogen's effects on mitochondrial gene expression: mechanisms and potential contributions to estrogen carcinogenesis, Ann N Y Acad Sci1028: 258-272.
35.
Clemente, C., Caruso, M.G., Berloco, P., Notarnicola, M., D'Attoma, B., Osella, A.R. et al. (1999) Antioxidant effect of short-term hormonal treatment in postmenopausal women, Maturitas31: 137-142.
36.
Crompton, M., Moser, R., Ludi, H. and Carafoli, E. (1978) The interrelations between the transport of sodium and calcium in mitochondria of various mammalian tissues, Eur J Biochem82: 25-31.
37.
Corasaniti, M.T., Amantea, D., Russo, R., Piccirilli, S., Leta, A., Corazzari, M. et al. (2005) 17beta-estradiol reduces neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat, Neurotoxicology26: 893-903.
38.
Cruz, J.C. and Tsai, L.H. (2004) A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease, Curr Opin Neurobiol14: 390-94.
39.
Culmsee, C., Vedder, H., Ravati, A., Junker, V., Otto, D., Ahlemeyer, B. et al. (1999) Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism, J Cereb Blood Flow Metab19: 1263-1269.
40.
Davis, J.B. and Maher, P. (1994) Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line, Brain Res652: 169-173.
De Girolamo, L.A., Hargreaves, A.J. and Billett, E.E. (2001) Protection from MPTP-induced neurotoxicity in differentiating mouse N2a neuroblastoma cells, J Neurochem76: 650-660.
43.
DeKosky, S.T., Abrahamson, E.E., Ciallella, J.R., Paljug, W.R., Wisniewski, S.R., Clark, R.S.B. et al. (2007) Association of increased cortical soluble A42 levels with diffuse plaques after severe brain injury in humans, Arch Neurol64: 541-544.
44.
Demonacos, C.V., Karayanni, N., Hatzoglou, E., Tsiriyiotis, C., Spandidos, D.A. and Sekeris, C.E. (1996) Mitochondrial genes as sites of primary action of steroid hormones, Steroids61: 226-232.
45.
Desmond, D.W., Moroney, J.T., Sano, M. and Stern, Y. (2002) Incidence of dementia after ischemic stroke: results of a longitudinal study, Stroke33: 2254-2260.
46.
DeVries, A.C., Nelson, R.J., Traystman, R.J. and Hurn, P.D. (2001) Cognitive and behavioral assessment in experimental stroke research: will it prove useful?, Neurosci Biobehav Rev25: 325-342.
47.
Dewar, D., Graham, D.I., Teasdale, G.M. and McCulloch, J. (1993) Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat, Acta Neuropathol86: 623-629.
48.
Dicko, A., Morissette, M., Ben Ameur, S., Pézolet, M. and Di Paolo, T. (1999) Effect of estradiol and tamoxifen on brain membranes: investigation by infrared and fluorescence spectroscopy, Brain Res Bull49: 401-405.
49.
Disshon, K.A. and Dluzen, D.E. (1997) Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release, Brain Res764: 9-16.
50.
Dluzen, D.E., McDermott, J.L. and Liu, B. (1996) Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release, J Neurochem66: 658-666.
51.
Dluzen, D. and Horstink, M. (2003) Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies, Endocrine21: 67-75.
Dubal, D.B., Shughrue, P.J., Wilson, M.E., Merchenthaler, I. and Wise, P.M. (1999) Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors, J Neurosci19: 6385-6393.
54.
Dykens, J.A., Simpkins, J.W., Wang, J. and Gordon, K. (2003) Polycyclic phenols, estrogens and neuroprotection: a proposed mitochondrial mechanism, Exp Gerontol38: 101-107.
55.
Espeland, M.A., Rapp, S.R., Shumaker, S.A., Brunner, R., Manson, J.E., Sherwin, B.B. et al. (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study, J Amer Med Assoc291: 2959-2968.
56.
Feng, Z. and Zhang, J.T. (2005) Long-term melatonin or 17beta-estradiol supplementation alleviates oxidative stress in ovariectomized adult rats, Free Radic Biol Med39: 195-204.
57.
Fillit, H., Weinreb, H., Cholst, I., Luine, V., McEwen, B.Amador, R. et al. (1986) Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type, Psychoneuroendocrinology11: 337-345.
58.
Fitzpatrick, J.L., Mize, A.L., Wade, C.B., Harris, J.A., Shapiro, R.A. and Dorsa, D.M. (2002) Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expressionof estrogen receptor alpha or beta and activation of the MAPK pathway, J Neurochem82: 674-682.
59.
Fukuda, K., Yao, H., Ibayashi, S., Nakahara, T., Uchimura, H., Fujishima, M. et al. (2000) Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats, Stroke31: 155-160.
60.
Gagné, B., Gélinas, S., Bureau, G., Lagacé, B., Ramassamy, C., Chiasson, K. et al. (2003) Effects of estradiol, phytoestrogens, and Ginkgo biloba extracts against 1-methyl-4-phenylpyridine-induced oxidative stress, Endocrine21: 89-95.
61.
Gélinas, S., Bureau, G., Valastro, B., Massicotte, G., Cicchetti, F., Chiasson, K. et al. (2004) Alpha and beta estradiol protect neuronal but not native PC12 cells from paraquat-induced oxidative stress, Neurotox Res6: 141-148.
62.
Gollapudi, L. and Oblinger, M.M. (1999) Stable transfection of PC12 cells with estrogen receptor (ERalpha): protective effects of estrogen on cell survival after serum deprivation, J Neurosci Res56: 99-108.
63.
Goodman, Y., Bruce, A.J., Cheng, B. and Mattson, M.P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons, J Neurochem66: 1836-1844.
64.
Green, P.S., Gridley, K.E. and Simpkins, J.W. (1996) Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells, Neurosci Lett218: 165-168.
65.
Green, P.S., Bishop, J. and Simpkins, J.W. (1997a) 17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells, J Neurosci17: 511-515.
66.
Green, P.S., Gordon, K. and Simpkins, J.W. (1997b) Phenolic A ring requirement for the neuroprotective effects of steroids, J Steroid Biochem Mol Biol63: 229-235.
67.
Green, P.S., Gridley, K.E. and Simpkins, J.W. (1998) Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione, Neuroscience84: 7-10.
68.
Green, P.S., Bales, K., Paul, S. and Bu, G. (2005) Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease, Endocrinology146: 2774-2781.
69.
Green, P.S., Yang, S.H., Nilsson, K.R., Kumar, A.S., Covey, D.F. and Simpkins, J.W. (2001) The nonfeminizing enantiomer of 17beta-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia, Endocrinology142: 400-6.
70.
Greenfield, J.P., Leung, L.W., Cai, D., Kaasik, K., Gross, R.S., Rodriguez-Boulan, E. et al. (2002) Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis, J Biol Chem277: 12128-12136.
71.
Gridley, K.E., Green, P.S. and Simpkins, J.W. (1998) A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro, Mol Pharmacol54: 874-880.
72.
Harman, S.M. (2006) Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS, Gend Med3: 254-269.
73.
Hawk, T., Zhang, Y.Q., Rajakumar, G., Day, A.L. and Simpkins, J.W. (1998) Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats, Brain Res796: 296-298.
74.
Hawkins, V., Shen, Q. and Chiueh, C.C. (1999) Kynostatin and 17beta-estradiol prevent the apoptotic death of human neuroblastoma cells exposed to HIV-1 protease, J Biomed Sci6: 433-438.
75.
He, Z., He, Y.J., Day, A.L. and Simpkins, J.W. (2002) Proestrus levels of estradiol during transient global cerebral ischemia improves the histological outcome of the hippocampal CA1 region: perfusion-dependent and-independent mechanisms, J Neurol Sci193: 79-87.
76.
Henderson, V.W., Stanford, C.A., Espeland, M.A., Hogan, P.E., Rapp, S.R., Stefanick, M.L. et al. (2007) Prior use of hormone therapy and incident Alzheimer's disease in the Women's Health Initiative Memory Study. American Academy of Neurology 59th Annual Meeting: Abstract S31.004..
77.
Henon, H., Durieu, I., Guerouaou, D., Lebert, F., Pasquier, F. and Leys, D. (2001) Poststroke dementia: incidence and relationship to prestroke cognitive decline, Neurology57: 1216-1222.
78.
Honda, K., Sawada, H., Kihara, T., Urushitani, M., Nakamizo, T., Akaike, A. et al. (2000) Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons, J Neurosci Res60: 321-327.
79.
Honda, K., Shimohama, S., Sawada, H., Kihara, T., Nakamizo, T., Shibasaki, H. et al. (2001) Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons, J Neurosci Res64: 466-475.
80.
Horvat, A., Nikezi, G., Petrovi, S. and Kanazir, D.T. (2001) Binding of estradiol to synaptosomal mitochondria: physiological significance, Cell Mol Life Sci58: 636-644.
81.
Horvat, A., Petrovi, S., Nedeljkovi, N., Martinovi, J.V. and Nikezi, G. (2000) Estradiol affect Na-dependent Ca2+ efflux from synaptosomal mitochondria, Gen Physiol Biophys19: 59-71.
82.
Hosoda, T., Nakajima, H. and Honjo, H. (2001) Estrogen protects neuronal cells from amyloid beta-induced apoptotic cell death, Neuroreport12: 1965-1970.
83.
Howard, S.A., Brooke, S.M. and Sapolsky, R.M. (2001) Mechanisms of estrogenic protection against gp120-induced neurotoxicity, Exp Neurol168: 385-391.
84.
Howell, A., DeFriend, D.J., Robertson, J.F., Blamey, R.W., Anderson, L. et al. (1996) Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer, Br J Cancer74: 300-308.
85.
Ikeda, K., Akiyama, H., Arai, T., Kondo, H., Haga, C., Tsuchiya, K. et al. (2000) Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain?, Neurosci Lett284: 187-189.
86.
Ikonomovic, M.D., Uryu, K., Abrahamson, E.E., Ciallella, J.R., Trojanowski, J.Q., Lee, V.M.-Y. et al. (2004) Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury, Exp Neurol190: 192-203.
87.
Jaffe, A.B., Toran-Allerand, C.D., Greengard, P. and Gandy, S.E. (1994) Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein, J Biol Chem269: 13065-13068.
88.
Jellinger, K.A., Paulus, W., Wrocklage, C. and Litvan, I. (2001) Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease, Eur J Neurol8: 707-710.
89.
Jung, M.E., Rewal, M., Perez, E., Wen, Y. and Simpkins, J.W. (2004) Estrogen protects against brain lipid peroxidation in ethanol-withdrawn rats, Pharmacol Biochem Behav79: 573-586.
90.
Jung, M.E., Wilson, A.M. and Simpkins, J.W. (2006) A nonfeminizing estrogen analog protects against ethanol withdrawal toxicity in immortalized hippocampal cells, J Pharmacol Exp Ther319: 543-550.
91.
Karhunen, H., Pitkanen, A., Virtanen, T., Gureviciene, I., Pussinen, R., Ylinen, A. et al. (2003) Long-term functional consequences of transient occlusion of the middle cerebral artery in rats: a 1-year follow-up of the development of epileptogenesis and memory impairment in relation to sensorimotor deficits, Epilepsy Res54: 1-10.
92.
Kajta, M., Budziszewska, B., Marsza, M. and Laso, W. (2001) Effects of 17-beta estradiol and estriol on NMDA-induced toxicity and apoptosis in primary cultures of rat cortical neurons, J Physiol Pharmacol52: 437-446.
93.
Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A. et al. (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging, Neurology48: 1517-1521.
94.
Kenchappa, R.S., Diwakar, L., Annepu, J. and Ravindranath, V. (2004) Estrogen and neuroprotection: higher constitutive expression of glutaredoxin in female mice offers protection against MPTP-mediated neurodegeneration, FASEB J18: 1102-1104.
95.
Kendall, S.L., Anderson, C.F., Nath, A., Turchan-Cholewo, J., Land, C.L., Mactutus, C.F. et al. (2005) Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism , BMC Neurosci6: 40.
96.
Kesavapany, S., Li, B.S., Amin, N., Zheng, Y.L., Grant, P. and Pant, H.C. (2004) Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide , Biochim Biophys Acta1697: 143-153.
97.
Kim, H., Bang, O.Y., Jung, M.W., Ha, S.D., Hong, H.S., Huh, K. et al. (2001) Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells, Neurosci Lett302: 58-62.
98.
Kokmen, E., Whisnant, J.P., O'Fallon, W.M., Chu, C.P. and Beard, C.M. (1996) Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984), Neurology46: 154-159.
99.
Kumar, D.M., Perez, E., Cai, Z.Y., Aoun, P., Brun-Zinkernagel, A.M., Covey, D.F. et al. (2005) Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity, Free Radic Biol Med38: 1152-1163.
100.
Kuroki, Y., Fukushima, K., Kanda, Y., Mizuno, K. and Watanabe, Y. (2001) Neuroprotection by estrogen via extracellular signal-regulated kinase against quinolinic acid-induced cell death in the rat hippocampus, Eur J Neurosci13: 472-476.
Lei, D.L., Long, J.M., Hengemihle, J., O'Neill, J., Manaye, K.F., Ingram, D.K. and Mouton, P.R. (2003) Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice, Neuroscience121: 659-666.
103.
Levin-Allerhand, J.A., Lominska, C.E., Wang, J. and Smith, J.D. (2002) 17Alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice, J Alzheimers Dis4: 449-457.
104.
Li, R., Shen, Y., Yang, L.B., Lue, L.F., Finch, C. and Rogers, J. (2000) Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex, J Neurochem75: 1447-1454.
105.
Liang, Y., Belford, S., Tang, F., Prokai, L., Simpkins, J.W. and Hughes, J.A. (2001) Membrane fluidity effects of estratrienes, Brain Res Bull54: 661-668.
106.
Liu, R., Yang, S.H., Perez, E., Yi, K.D., Wu, S.S., Eberst, K. et al. (2002) Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis, Stroke33: 2485-2491.
107.
Liu, X., Fan, X.L., Zhao, Y., Luo, G.R., Li, X.P., Li, R. et al. (2005) Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia, J Neurosci Res81: 653-665.
108.
Loeb, C., Gandolfo, C., Croce, R. and Conti, M. (1992) Dementia associated with lacunar infarction, Stroke23: 1225-1229.
109.
Maki, P.M., Zonderman, A.B. and Resnick, S.M. (2001) Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy, Am J Psychiatry158: 227-233.
110.
Manson, J.E., Hsia, J., Johnson, K.C., Rossouw, J.E., Assaf, A.R. et al. (2003) Estrogen plus progestin and the risk of coronary heart disease, N Eng J Med349: 523-534.
111.
Markgraf, C.G., Green, E.J., Hurwitz, B.E., Morikawa, E., Dietrich, W.D. et al. (1992) Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats, Brain Res575: 238-246.
112.
Markgraf, C.G., Green, E.J., Watson, B., McCabe, P.M., Schneiderman, N., Dietrich, W.D. et al. (1994) Recovery of sensorimotor function after distal middle cerebral artery photothrombotic occlusion in rats, Stroke25: 153-159.
113.
Markgraf, C.G., Johnson, M.P., Braun, D.L. and Bickers, M.V. (1997) Behavioral recovery patterns in rats receiving the NMDA receptor antagonist MDL 100,453 immediately post-stroke, Pharmacol Biochem Behav56: 391-397.
114.
Martín, C., Barturen, K., Martínez, R., Lacort, M. and Ruiz-Larrea, M.B. (1998) In vitro inhibition by estrogens of the oxidative modifications of human lipoproteins, J Physiol Biochem54: 195-202.
115.
Mattson, M.P., Robinson, N. and Guo, Q. (1997) Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1 , Neuroreport8: 3817-3821.
116.
McManus, J., McEneny, J., Young, I.S. and Thompson, W. (1996) The effect of various oestrogens and progestogens on the susceptibility of low density lipoproteins to oxidation in vitro, Maturitas25: 125-131.
117.
Mendelowitsch, A., Ritz, M.F., Ros, J., Langemann, H. and Gratzl, O. (2001) 17beta-Estradiol reduces cortical lesion size in the glutamate excitotoxicity model by enhancing extracellular lactate: a new neuroprotective pathway, Brain Res901: 230-236.
118.
Mérot, Y., Ferrière, F., Debroas, E., Flouriot, G., Duval, D. and Saligaut, C. (2005) Estrogen receptor alpha mediates neuronal differentiation and neuroprotection in PC12 cells: critical role of the A/B domain of the receptor, J Mol Endocrinol35: 257-267.
119.
Miller, C.P., Jirkovsky, I., Hayhurst, D.A. and Adelman, S.J. (1996) In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper induced oxidation of low density lipoprotein , Steroids61: 305-308.
120.
Mitsios, N., Pennucci, R., Krupinski, J., Sanfeliu, C., Gaffney, J., Kumar, P. et al. (2007) Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke, Brain Pathol17: 11-23.
121.
Monaco, E.A. 3rd and M.L. Vallano (2005) Role of protein kinases in neurodegenerative disease: cyclin-dependent kinases in Alzheimer's disease, Front Biosci10: 143-159.
122.
Mook-Jung, I., Joo, I., Sohn, S., Kwon, H.J., Huh, K. and Jung, M.W. (1997) Estrogen blocks neurotoxic effects of beta-amyloid (1-42) and induces neurite extension on B103 cells, Neurosci Lett235: 101-104.
123.
Moosmann, B. and Behl, C. (1999) The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties, Proc Natl Acad Sci U S A96: 8867-8872.
124.
Morinaga, A., Hirohata, M., Ono, K. and Yamada, M. (2007) Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro, Biochem Biophys Res Commun359: 697-702.
125.
Morkuniene, R., Jekabsone, A. and Borutaite, V. (2002) Estrogens prevent calcium-induced release of cytochrome c from heart mitochondria, FEBS Lett521: 53-56.
126.
Mulnard, R.A., Cotman, C.W., Kawas, C., van Dyck, C.H., Sano, M., Doody, R. et al. (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study, J Amer Med Assoc283: 1007-1015.
127.
Nakamizo, T., Urushitani, M., Inoue, R., Shinohara, A., Sawada, H., Honda, K. et al. (2000) Protection of cultured spinal motor neurons by estradiol, Neuroreport11: 3493-3497.
128.
Nilsen, J. and Brinton, R.D. (2004) Mitochondria as therapeutic targets of estrogen action in the central nervous system, Curr Drug Targets CNS Neurol Disord3: 297-313.
129.
Nilsen, J. and Brinton, R.D. (2003) Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression, Proc Natl Acad Sci USA100: 2842-2847.
130.
Nilsen, J., Irwin, R.W., Gallaher, T.K. and Brinton, R.D. (2007) Estradiol in vivo regulation of brain mitochondrial proteome, J Neurosci. 27: 14069-77.
131.
Noteboom, W.D. and Gorski, J. (1965) Stereospecific binding of estrogens in the rat uterus, Arch Biochem Biophys111: 559-568.
132.
Ohkura, T., Isse, K., Akazawa, K., Hamamoto, M., Yaoi, Y. and Hagino, N. (1994) Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type, Endocr J41: 361-371.
133.
Olivieri, G., Novakovic, M., Savaskan, E., Meier, F., Baysang, G., Brockhaus, M. et al. (2002) The effects of beta-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion, Neuroscience113: 849-855.
134.
Olsson, A., Csajbok, L., Ost, M., Hoöglund, K., Nylén, K., Rosengren, L., Nellgard, B. and Blennow, K. (2004) Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury, J Neurol251: 870-876.
135.
Paganini-Hill, A. and Henderson, V. (1994) Estrogen deficiency and risk of Alzheimer's disease in women, Am J Epidemiol140: 256-261.
136.
Paganini-Hill, A. and Henderson, V.W. (1996) Estrogen replacement therapy and risk of Alzheimer disease, Arch Intern Med156: 2213-2217.
137.
Park, O.J. (2001) Comparison of estrogen and genistein in their antigenotoxic effects, apoptosis and signal transduction protein expression patterns, Biofactors21: 379-382.
138.
Pasquier, F. and Leys, D. (1997) Why are stroke patients prone to develop dementia? , J Neurol244: 135-142.
139.
Perez, E., Liu, R., Yang, S.H., Cai, Z.Y., Covey, D.F. and Simpkins, J.W. (2005) Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo, Brain Res1038: 216-222.
140.
Perez, E., Cai, Z.Y., Covey, D.F. and Simpkins, J.W. (2006) Neuroprotective effects of estratriene analogs: structure-activity relationships and molecular optimization, Drug Development Research68: 78-92.
141.
Petanceska, S.S., Nagy, V., Frail, D. and Gandy, S. (2000) Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain, Neurology54: 2212-2217.
142.
Petrovic, S., Demajo, M. and Horvat, A. (2005) Estradiol affects calcium transport across mitochondrial membrane in different brain regions, Ann N Y Acad Sci1048: 341-343.
143.
Phillips, S.M. and Sherwin, B.B. (1992) Effects of estrogen on memory function in surgically menopausal women, Psychoneuroendocrinology17: 485-495.
144.
Pohjasvaara, T., Mantyla, R., Ylikoski, R., Kaste, M. and Erkinjuntti, T. (2000) Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences, Stroke31: 2952-2957.
145.
Prokai, L., Prokai-Tatrai, K., Perjesi, P., Zharikova, A.D., Perez, E.J., Liu, R. and Simpkins, J.W. (2003) Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection, Proc Natl Acad Sci U S A100: 11741-11746.
146.
Rapp, S.R., Espeland, M.A., Shumaker, S.A., Henderson, V.W., Brunner, R.L., Manson, J.E. et al. (2003) Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial, J Amer Med Assoc289: 2663-2672.
147.
Regan, R.F. and Guo, Y. (1997) Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures, Brain Res764: 133-140.
148.
Resnick, S.M. and Maki, P.M. (2001) Effects of hormone replacement therapy on cognitive and brain aging, Ann N Y Acad Sci949: 203-214.
149.
Resnick, S.M., Maki, P.M., Golski, S., Kraut, M.A. and Zonderman, A.B. (1998) Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance, Horm Behav34: 171-182.
150.
Roman, G.C. (2002) Vascular dementia may be the most common form of dementia in the elderly, J Neurol Sci203-204: 7-10.
151.
Roman, G.C., Erkinjuntti, T., Wallin, A., Pantoni, L. and Chui, H.C. (2002) Subcortical ischaemic vascular dementia, Lancet Neurol1: 426-436.
152.
Roömer, W., Oettel, M., Menzenbach, B., Droescher, P. and Schwarz, S. (1997) Novel estrogens and their radical scavenging effects, iron-chelating, and total antioxidative activities: 17 alpha-substituted analogs of delta 9(11)-dehydro-17 beta-estradiol, Steroids62: 688-694.
153.
Roof, R.L., Schielke, G.P., Ren, X. and Hall, E.D. (2001) A comparison of long-term functional outcome after 2 middle cerebral artery occlusion models in rats, Stroke32: 2648-2657.
154.
Ruiz-Larrea, M.B., Leal, A.M., Liza, M., Lacort, M. and de Groot, H. (1994) Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes, Steroids59: 383-388.
155.
Ruiz-Larrea, B., Leal, A., Martín, C., Martínez, R. and Lacort, M. (1995) Effects of estrogens on the redox chemistry of iron: a possible mechanism of the antioxidant action of estrogens, Steroids60: 780-783.
156.
Russo, R., Navarra, M., Maiuolo, J., Rotiroti, D., Bagetta, G. and Corasaniti, M.T. (2005) 17beta-estradiol protects SH-SY5Y Cells against HIV-1 gp120-induced cell death: evidence for a role of estrogen receptors, Neurotoxicology26: 905-13.
157.
Sack, M.N., Rader, D.J. and Cannon, R.O. (1994) Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women, Lancet343: 269-270.
158.
Sagara, Y. (1998) Induction of reactive oxygen species in neurons by haloperidol, J Neurochem71: 1002-1012.
159.
Samuelsson, M., Soderfeldt, B. and Olsson, G.B. (1996) Functional outcome in patients with lacunar infarction , Stroke27: 842-846.
160.
Sasaki, K., Sato, M. and Umezawa, Y. (2003) Fluorescent indicators for Akt/protein kinase B and dynamics of Akt activity visualized in living cells, J Biol Chem278: 30945-30951.
161.
Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A. and Shimohama, S. (1998) Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death, J Neurosci Res54: 707-719.
162.
Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Honda, K., Nakanishi, M. et al. (2000) Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons, FASEB J14: 1202-1214.
163.
Schmidt, A.J., Krieg, J.C. and Vedder, H. (2002) Differential effects of glucocorticoids and gonadal steroids on glutathione levels in neuronal and glial cell systems, J Neurosci Res67: 544-550.
164.
Schneider, L.S., Farlow, M.R., Henderson, V.W. and Pogoda, J.M. (1996) Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease, Neurology46: 1580-1584.
165.
Schwenke, D.C., Wagner, J.D. and Adams, M.R. (1999) In vitro lipid peroxidation of LDL from postmenopausal cynomolgus macaques treated with female hormones, J Lipid Res40: 235-244.
166.
Sherwin, B.B. (1997) Estrogen effects on cognition in menopausal women , Neurology48: S21-S26.
167.
Shi, J., Panickar, K.S., Yang, S.H., Rabbani, O., Day, A.L. and Simpkins, J.W. (1998) Estrogen attenuates over-expression of beta-amyloid precursor protein messager RNA in an animal model of focal ischemia, Brain Res810: 87-92.
168.
Shoulson, I. (1998) Experimental therapeutics of neurodegenerative disorders: unmet needs, Science282: 1072-1074.
169.
Shughrue, P.J. (2004) Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta), Exp Neurol. 190: 468-77.
170.
Shumaker, S.A., Legault, C., Kuller, L., Rapp, S.R., Thal, L., Lane, D.S. et al. (2004) Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study, J Amer Med Assoc291: 2947-2958.
171.
Shumaker, S.A., Legault, C., Rapp, S.R., Thal, L., Wallace, R.B., Ockene, J.K. et al. (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial, J Amer Med Assoc289: 2651-2662.
172.
Sierens, J., Hartley, J.A., Campbellm, M.J., Leathem, A.J. and Woodside, J.V. (2001) Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay, Mutat Res485: 169-176.
173.
Simpkins, J.W., Rajakumar, G., Zhang, Y.Q., Simpkins, C.E., Greenwald, D., Yu, C.J. et al. (1997) Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat, J Neurosurg87: 724-730.
174.
Simpkins, J.W., Yang, S.H., Liu, R., Perez, E., Cai, Z.Y., Covey, D.F. et al. (2004) Estrogen-like compounds for ischemic neuroprotection , Stroke35(11 Suppl. 1): 2648-2651.
175.
Simpkins, J.W., Wang, J., Wang, X., Perez, E., Prokai, L. and Dykens, J.A. (2005a) Mitochondria play a central role in estrogen-induced neuroprotection, Curr Drug Targets CNS Neurol Disord4: 69-83.
176.
Simpkins, J.W., Wen, Y., Perez, E., Yang, S. and Wang, X. (2005b) Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology , Ann N Y Acad Sci1052: 233-242.
177.
Simpkins, J.W., Yang, S.H., Wen, Y. and Singh, M. (2005c) Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies, Cell Mol Life Sci62: 271-280.
178.
Singer, C.A., Rogers, K.L. and Dorsa, D.M. (1998) Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons, Neuroreport9: 2565-2568.
179.
Singh, M. and Simpkins, J.W. (2005) The Future of Hormone Therapy: What Basic Science and Clinical Studies Teach Us. New York Academy of Science , New York.
180.
Singh, M., Sumien, N., Kyser, C. and Simpkins, J.W. (2008) Estrogens and progesterone as neuroprotectants: what animal models teach us, Front Biosci13: 1083-1089.
181.
Smith, S.E., Hodges, H., Sowinski, P., Man, C.M., Leach, M.J., Sinden, J.D. et al. (1997) Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat, Neuroscience77: 1123-1135.
182.
Solakidi, S., Psarra, A.M., Nikolaropoulos, S. and Sekeris, C.E. (2005) Estrogen receptors alpha and beta (ERalpha and ERbeta) and androgen receptor (AR) in human sperm: localization of ERbeta and AR in mitochondria of the midpiece, Hum Reprod20: 3481-87.
183.
Sortino, M.A., Chisari, M., Merlo, S., Vancheri, C., Caruso, M. and Nicoletti, F. (2004) Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death, Endocrinology145: 5080-5086.
184.
Sribnick, E.A., Ray, S.K., Nowak, M.W., Li, L. and Banik, N.L. (2004) 17beta-estradiol attenuates glutamate-induced apoptosis and preserves electrophysiologic function in primary cortical neurons, J Neurosci Res76: 688-696.
185.
Stirone, C., Duckles, S.P., Krausem, D.N. and Procaccio, V. (2005) Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels, Mol Pharmacol68: 959-965.
186.
Stroemer, R.P., Kent, T.A. and Hulsebosch, C.E. (1998) Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats, Stroke29: 2381-2393.
187.
Sudo, S., Wen, T.C., Desaki, J., Matsuda, S., Tanaka, J., Arai, T. et al. (1997) Beta-estradiol protects hippocampal CA1 neurons against transient forebrain ischemia in gerbil, Neurosci Res29: 345-354.
Takao, T., Flint, N., Lee, L., Ying, X., Merrill, J. and Chandross, K.J. (2004) 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death, J Neurochem89: 660-673.
190.
Tamura, A., Graham, D.I., McCulloch, J. and Teasdale, G.M. (1981) Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion, J Cereb Blood Flow Metab1: 53-60.
191.
Tang, M., Abplanalp, W., Ayres, S. and Subbiah, M.T. (1996a) Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation, Metabolism45: 411-414.
192.
Tang, M.X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B. et al. (1996b) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease, Lancet348: 429-432.
193.
Tatemichi, T.K., Foulkes, M.A., Mohr, J.P., Hewitt, J.R., Hier, D.B., Price, T.R. et al. (1990) Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings, Stroke21: 858-866.
194.
Tatemichi, T.K., Paik, M., Bagiella, E., Desmond, D.W., Stern, Y., Sano, M. et al. (1994) Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study, Neurology44: 1885-1891.
195.
Telci, A., Cakatay, U., Akhan, S.E., Bilgin, M.E., Turfanda, A. and Sivas, A. (2002) Postmenopausal hormone replacement therapy use decreases oxidative protein damage, Gynecol Obstet Invest54: 88-93.
196.
Thibodeau, P.A., Kachadourian, R., Lemay, R., Bisson, M., Day, B.J. and Paquette, B. (2002) In vitro pro- and antioxidant properties of estrogens , J Steroid Biochem Mol Biol81: 227-236.
197.
Toung, T.J., Traystman, R.J. and Hurn, P.D. (1998) Estrogen-mediated neuroprotection after experimental stroke in male rats, Stroke29: 1666-1670.
198.
Toung, T.K., Hurn, P.D., Traystman, R.J. and Sieber, F.E. (2000) Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type 1 diabetes mellitus, Stroke31: 2701-2706.
199.
Turchan, J., Anderson, C., Hauser, K.F., Sun, Q., Zhang, J., Liu, Y., Wise, P.M., Kruman, I., Maragos, W., Mattson, M.P., Booze, R. and Nath, A. (2001) Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine, BMC Neurosci2: 3.
200.
Van Den Heuvel, C., Thornton, E. and Vink, R. (2007) Traumatic brain injury and Alzheimer's disease: a review, Prog Brain Res161: 303-316.
201.
Van Itallie, C.M. and Dannies, P.S. (1998) Estrogen induces accumulation of the mitochondrial ribonucleic acid for subunit II of cytochrome oxidase in pituitary tumor cells , Mol Endocrinol2: 332-337.
202.
Vassar, R. (2007) Caspase-3 cleavage of GGA3 stabilizes BACE: implications for Alzheimer's disease, Neuron54: 671-673.
203.
Vedder, H., Anthes, N., Stumm, G., Wurz, C., Behl, C. and Krieg, J.C. (1999) Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system, J Neurochem72: 2531-38.
204.
Vedder, H., Teepker, M., Fischer, S. and Krieg, J.C. (2000) Characterization of the neuroprotective effects of estrogens on hydrogen peroxide-induced cell death in hippocampal HT22 cells: time and dose-dependency, Exp Clin Endocrinol Diabetes108: 120-127.
205.
Vegeto, E., Bonincontro, C., Pollio, G., Sala, A., Viappiani, S., Nardi, F. et al. (2001) Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia, J Neurosci21: 1809-1818.
206.
Wallace, D.R., Dodson, S., Nath, A. and Booze, R.M. (2006) Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function, Synapse59: 51-60.
207.
Wang, X., Simpkins, J.W., Dykens, J.A. and Cammarata, P.R. (2003) Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability, Invest Ophthalmol Vis Sci44: 2067-2075.
208.
Wang, J., Green, P.S. and Simpkins, J.W. (2001) Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SKN- SH human neuroblastoma cells, J Neurochem77: 804-811.
209.
Wen, Y., Onyewuchi, O., Yang, S., Liu, R. and Simpkins, J.W. (2004a) Increased beta-secretase activity and expression in rats following transient cerebral ischemia, Brain Res1009: 1-8.
210.
Wen, Y., Yang, S., Liu, R. and Simpkins, J.W. (2004b) Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein, Brain Res1022: 30-38.
211.
Wen, Y., Yu, W.H., Maloney, B., Bailey, J., Ma, J., Marié, I. et al. (2008) Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing, Neuron57: 680-690.
212.
Whiting, K.P., Restall, C.J. and Brain, P.F. (2000) Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms, Life Sci67: 743-757.
213.
Winterle, J.S., Mill, T., Harris, T. and Goldbeck, R.A. (2001) Absolute kinetic characterization of 17-beta-estradiol as a radical-scavenging, antioxidant synergist, Arch Biochem Biophys392: 233-244.
214.
Wise, P.M., Dubal, D.B., Wilson, M.E., Rau, S.W., Boöttner, M. and Rosewell, K.L. (2001) Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies, Brain Res Brain Res Rev37: 313-319.
215.
Wiseman, H. (1994) The antioxidant action of a pure antioestrogen: ability to inhibit lipid peroxidation compared to tamoxifen and 17 beta-oestradiol and relevance to its anticancer potential, Biochem Pharmacol47: 493-498.
216.
Yang, S.H., He, Z., Wu, S.S., He, Y.J., Cutright, J., Millard, W.J. et al. (2001) 17-beta estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage, J Cereb Blood Flow Metab21: 174-181.
217.
Yang, S.H., Liu, R., Perez, E.J., Wen, Y., Stevens, S.M. Jr, Valencia, T., Brun-Zinkernagel, A.M. et al. (2004) Mitochondrial localization of estrogen receptor beta, Proc Natl Acad Sci U S A101: 4130-4135.
218.
Yonemori, F., Yamada, H., Yamaguchi, T., Uemura, A. and Tamura, A. (1996) Spatial memory disturbance after focal cerebral ischemia in rats, J Cereb Blood Flow Metab16: 973-980.
219.
Yonemori, F., Yamaguchi, T., Yamada, H. and Tamura, A. (1999) Spatial cognitive performance after chronic focal cerebral ischemia in rats, J Cereb Blood Flow Metab19: 483-494.
220.
Yi, K.D., Chung, J., Pang, P. and Simpkins, J.W. (2005) Role of protein phosphatases in estrogen-mediated neuroprotection, J Neurosci25: 7191-7198.
221.
Yi, K.D., Cai, Z.Y., Covey, D.F. and Simpkins, J.W. (2008) Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation, J Pharmacol Exp Ther324: 1188-1195.
222.
Yu, X., Rajala, R.V., McGinnis, J.F., Li, F., Anderson, R.E., Yan, X. et al. (2004) Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 beta-estradiolmediated neuroprotection, J Biol Chem279: 13086-13094.
223.
Zandi, P.P., Carlson, M.C., Plassman, B.L., Welsh-Bohmer, K.A., Mayer, L.S., Steffens, D.C. et al. (2002) Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study, J Amer Med Assoc288: 2123-2129.
224.
Zemlyak, I., Brooke, S.M. and Sapolsky, R.M. (2002) Protection against gp120-induced neurotoxicity by an array of estrogenic steroids, Brain Res958: 272-276.
225.
Zemlyak, I., Brooke, S. and Sapolsky, R. (2005) Estrogenic protection against gp120 neurotoxicity: role of microglia, Brain Res1046: 130-136.
226.
Zhao, L., Wu, T.W. and Brinton, R.D. (2004) Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons , Brain Res1010: 22-34.
227.
Zhao, L., O'Neill, K. and Diaz Brinton, R. (2005) Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs, Brain Res Brain Res Rev49: 472-493.
228.
Zhao, L., O'Neill, K. and Brinton, R.D. (2006) Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile , J Pharmacol Exp Ther319: 1124-32.
229.
Zhao, L., Jin, C., Mao, Z., Gopinathan, M.B., Rehder, K. and Brinton, R.D. (2007) Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator - a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons, J Med Chem50: 4471-4481.
230.
Zhang, Y. and Bhavnani, B.R. (2005) Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release, BMC Neurosci6: 13.
231.
Zheng, J. and Ramirez, V.D. (2000) Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals, Br J Pharmacol130: 1115-1123.
232.
Zheng, J. and Ramirez, V.D. (1999a) Purification and identification of an estrogen binding protein from rat brain: oligomycin sensitivity-conferring protein (OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase, J Steroid Biochem Mol Biol68: 65-75.
233.
Zheng, J. and Ramirez, V.D. (1999b) Rapid inhibition of rat brain mitochondrial proton F0F1-ATPase activity by estrogens: comparison with Na+, K+ -ATPase of porcine cortex, Eur J Pharmacol368: 95-102.
234.
Zheng, H., Xu, H., Uljon, S.N., Gross, R., Hardy, K., Gaynor, J. et al. (2002) Modulation of A(beta) peptides by estrogen in mouse models, J Neurochem80: 191-196.
